© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Aspen Pharmacare Holdings Limited (APNHY) stock remained unchanged at $6.78 a share on OTC. The stock opened at $7.40, fluctuating between $6.78 to $7.40 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jan 30, 2026 | 6.74 | 6.81 | 6.74 | 6.78 | 6.13K |
| Jan 28, 2026 | 6.93 | 6.93 | 6.93 | 6.93 | 116 |
| Jan 26, 2026 | 7.00 | 7.00 | 7.00 | 7.00 | 563 |
| Jan 22, 2026 | 7.20 | 7.20 | 6.97 | 6.97 | 1.31K |
| Jan 16, 2026 | 7.40 | 7.40 | 7.40 | 7.40 | 4.12K |
| Jan 15, 2026 | 7.66 | 7.66 | 7.56 | 7.61 | 942 |
| Jan 12, 2026 | 7.20 | 7.20 | 7.18 | 7.18 | 1.82K |
| Jan 09, 2026 | 7.19 | 7.19 | 7.03 | 7.10 | 1.12K |
| Jan 08, 2026 | 6.74 | 6.74 | 6.74 | 6.74 | 1 |
| Jan 05, 2026 | 6.83 | 6.83 | 6.83 | 6.83 | 1K |
| Dec 31, 2025 | 6.49 | 6.93 | 6.49 | 6.58 | 1.31K |
| Dec 30, 2025 | 6.97 | 6.97 | 6.81 | 6.81 | 910 |
| Dec 29, 2025 | 6.90 | 7.02 | 6.81 | 7.02 | 3.85K |
| Dec 24, 2025 | 5.61 | 5.61 | 5.61 | 5.61 | 600 |
| Dec 23, 2025 | 5.51 | 5.51 | 5.50 | 5.50 | 384 |
| Dec 22, 2025 | 5.60 | 5.60 | 5.60 | 5.60 | 5.13K |
| Dec 17, 2025 | 5.35 | 5.59 | 5.35 | 5.59 | 1.43K |
| Dec 15, 2025 | 5.36 | 5.36 | 5.36 | 5.36 | 479 |
| Dec 12, 2025 | 5.61 | 5.61 | 5.54 | 5.54 | 389 |
| Dec 11, 2025 | 5.45 | 5.45 | 5.36 | 5.36 | 5.45K |
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.
| Employees | 8867 |
| Beta | 0.37 |
| Sales or Revenue | $43.36B |
| 5Y Sales Change% | 0.154% |
| Fiscal Year Ends | June |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |